ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites.
ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites. The company's technology is based on a network-based machine learning algorithm for integrative analysis of untargeted metabolomic data with other large-scale molecular information, including data from genes, proteins, drugs and diseases, transforming metabolomic data into actionable insights, enabling development of in-house therapeutics for patients suffering from liver diseases and ailments.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 5, 2020 | Series Unknown | — | 1 | — | — | Detail |
Oct 5, 2019 | Convertable Note | $200K | 2 | Good Growth Capital | — | Detail |
Apr 18, 2018 | Seed | $1.50M | 4 | Rivas Capital | — | Detail |
Mar 6, 2018 | Seed | — | 2 | — | — | Detail |
Sep 1, 2017 | Grant | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Good Growth Capital | Yes | Convertable Note |
Rivas Capital | Yes | Seed |
77 | — | Series Unknown |
TechU Ventures | — | Convertable Note |
Team Builder Ventures | — | Seed |
WorldQuant Ventures LLC | — | Seed |
Boston Angel Club | — | Seed |
MIT delta v | — | Grant |
MassChallenge | — | Non-Equity Assistant |